Top & Current
Mon, August 12, 2024
[ Mon, Aug 12th 2024
] - WOPRAI
Thu, August 8, 2024
[ Thu, Aug 08th 2024
] - WOPRAI
Fri, July 12, 2024
[ Fri, Jul 12th 2024
] - WOPRAI
Mon, June 24, 2024
[ Mon, Jun 24th 2024
] - WOPRAI
Tue, February 20, 2024
[ Tue, Feb 20th 2024
] - WOPRAI
Thu, December 21, 2023
[ Thu, Dec 21st 2023
] - WOPRAI
Tue, October 3, 2023
[ Tue, Oct 03rd 2023
] - WOPRAI
Mon, July 17, 2023
[ Mon, Jul 17th 2023
] - WOPRAI
Fri, June 23, 2023
[ Fri, Jun 23rd 2023
] - WOPRAI
Tue, May 30, 2023
[ Tue, May 30th 2023
] - WOPRAI
[ Tue, May 30th 2023
] - WOPRAI
Mon, May 15, 2023
[ Mon, May 15th 2023
] - WOPRAI
Thu, April 13, 2023
[ Thu, Apr 13th 2023
] - WOPRAI
Wed, March 1, 2023
[ Wed, Mar 01st 2023
] - WOPRAI
Thu, February 9, 2023
[ Thu, Feb 09th 2023
] - WOPRAI
Tue, December 20, 2022
[ Tue, Dec 20th 2022
] - WOPRAI
Gavin Clark-Gartner Maintained (CABA) at Buy with Decreased Target to $15 on, Aug 12th, 2024
Gavin Clark-Gartner of Evercore ISI Group, Maintained "Cabaletta Bio, Inc." (CABA) at Buy with Decreased Target from $25 to $15 on, Aug 12th, 2024.
Gavin has made no other calls on CABA in the last 4 months.
There are 3 other peers that have a rating on CABA. Out of the 3 peers that are also analyzing CABA, 0 agree with Gavin's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Gavin
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $25 on, Friday, August 9th, 2024
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $50 on, Friday, June 21st, 2024
- Ben Burnett of "Stifel" Maintained at Strong Buy and Held Target at $32 on, Monday, June 17th, 2024